Skip directly to page options Skip directly to A-Z link
Volume 27, Number 2—February 2021
Dispatch

Human Tacheng Tick Virus 2 Infection, China, 2019

Zhihui Dong1, Meihua Yang1, Zedong Wang1, Shuo Zhao, Songsong Xie, Yicheng Yang, Gang Liu, Shanshan Zhao, Jing Xie, Quan LiuComments to Author , and Yuanzhi WangComments to Author 
Author affiliations: Shihezi University, Shihezi, China (Z. Dong, M. Yang, Shuo Zhao, Y. Yang, G. Liu, Shanshan Zhao, Y. Wang); Foshan University, Foshan, China (Z. Wang, Q. Liu); First Affiliated Hospital of Shihezi University, Shihezi (S. Xie, J. Xie); Shihezi People’s Hospital, Shihezi (Y. Yang)

Main Article

Table

Results of immunofluorescence assay in detection of Tacheng tick virus 2 infection in a human, China*

Days after illness onset Sample type IFA titer
IgM IgG
Day 9
 Serum 1:40 <1:10
Urine <1:10 <1:10
CSF
 <1:10
 <1:10
Day 16
 Serum 1:20 1:10
Urine <1:10 <1:10
CSF
 <1:10
 <1:10
Day 40 Serum <1:10 1:80
Urine <1:10 <1:10
CSF <1:10 <1:10

*CSF, cerebrospinal fluid; IFA, immunofluorescence assay.

Main Article

1These authors contributed equally to this article.

Page created: December 23, 2020
Page updated: February 02, 2021
Page reviewed: February 02, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external